Did you know that people from the LGBTQ+ community seem to be more at risk for a mental health condition called Obsessive-Compulsive Disorder (OCD)? But how does their experience with OCD differ from their heterosexual peers? A recent study looked into this topic by examining the severity of OCD sym
Webtoon Entertainment, through its Japanese subsidiary LINE Digital Frontier, has made its first investment in a Japanese studio. The lucky recipient is No. 9, a prominent webcomic and manga studio based in Tokyo. This strategic move is aimed at boosting Webtoon's content pipeline in Japan, which is
Antibiotic resistance is a global problem, and misuse of these drugs is a significant contributor. In Romania, the scenario is particularly worrisome, as highlighted on Europe's map of antibiotic resistance. The efforts to tackle this issue rely heavily on healthcare professionals like general pract
Retinal image registration is crucial for tracking eye diseases and planning treatments. However, it's tricky due to significant changes in the images, limited overlap, and varying quality. Enter RetinaRegNet, a model that can handle different types of retinal images without needing to be retrained
Imagine a tiny, smart bomb designed to wipe out cancer cells and wake up the body’s immune system to fight back. This is the idea behind a new nanogel drug delivery system, DPCLG. It’s like a sneaky military operation, targeting two types of cells in the tumor’s neighborhood: cancer cells and immune
The Biden administration is preparing for a potential wave of student loan defaults, as borrowers who fell behind during the pandemic face collection activity again. This will be the first time in nearly five years that borrowers in default will have their wages and retirement benefits garnished. A
A new drug, upadacitinib, has been making waves in the treatment of severe eczema, also known as atopic dermatitis (AD). This medication is a Janus kinase (JAK) inhibitor, which means it stops certain enzymes from causing inflammation. It's been approved for kids aged 12 and above who have moderate
For many people living with schizophrenia, daily pills are the standard treatment. But what if there was a better way to manage this mental health condition? Long-acting injectable antipsychotics, or LAIs, might just be the game-changer. Unlike oral antipsychotics (OAPs), which patients have to reme
Bo Hines, a 29-year-old former football player and unsuccessful Congressional candidate, has taken the reins as the executive director of the Presidential Council of Advisers for Digital Assets. His path to this role hasn't been without some questionable stops. Before his appointment, Hines was back
Lowcountry schools are back to business as usual, but they're on high alert after a data breach at PowerSchool. The South Carolina Department of Education is helping out by looking into what went wrong. Something called personally identifiable information was compromised, and this isn't just a local
